Microtentacles on detached breast cancer cells

Tubulin microtentacles in detached mammary epithelial cells

NIH-funded research University of Maryland Baltimore · NIH-11210459

This work looks at whether blocking tiny tubulin-based 'microtentacles' on detached breast cancer cells can stop them from clumping and reattaching during spread.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11210459 on NIH RePORTER

What this research studies

The team studies how floating breast cancer cells form tubulin microtentacles that help them stick and seed new tumors. They will use drugs that alter the cell cortex and calcium signaling, measure cell mechanics with advanced imaging (Brillouin microscopy and atomic force microscopy), and watch how microtentacles change. Promising drugs will be tested for effects on cell reattachment in zebrafish and mouse models and on live patient tumor cells. The goal is to find interventions that reduce circulating tumor cell clustering and reattachment.

Who could benefit from this research

Good fit: Patients with breast cancer—particularly those with tumors at higher risk of spreading or with detectable circulating tumor cells—would be most relevant to this work.

Not a fit: People with cancers unrelated to breast tissue or patients whose disease is already well controlled are less likely to benefit directly from this specific research.

Why it matters

Potential benefit: If successful, this could lower the chance of breast cancer metastasis by preventing circulating tumor cells from clustering and reattaching.

How similar studies have performed: Prior lab and animal studies showed microtentacles help circulating tumor cells stick and seed metastases, but targeting them with the proposed kinase or TRPM8 pathway drugs in patient-derived cells is largely novel.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Anti-Cancer Agents
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.